12:00 - 13:20 
    Registration and Lunch
    13:20 - 13:30 
    Welcome from Founding Group Chair
    Kate Lines (Oxford, UK)
    13:30 - 14:00 
    NET Research Overview
    Speaker: Raj Thakker (Oxford, UK)
    Thu 29
    Research Summary Presentations
    VHL-deficient cell line
    Thu 29
    Research Summary Presentations
    Canine insulinoma: a model for human malignant insulinoma
    London, United Kingdom
    Thu 29
    Research Summary Presentations
    Pancreatic neuroendocrine neoplasms: exploring subgroup-defining biomarkers and therapeutic vulnerabilities in PNEN models
    Vancouver, Canada
    Thu 29
    Research Summary Presentations
    Development of new 3D in vitro models of Pancreatic Neuroendocrine Tumors (PanNET)
    Milan, Italy
    Thu 29
    Research Summary Presentations
    Therapeutic Screening in Patient Derived Organoids for Gastroenteropancreatic Neuroendocrine tumors
    Bethesda, USA
    Thu 29
    Research Summary Presentations
    Zebrafish patient derived xenografts as a tool for precision medicine: establishment of an in-vivo pipeline to evaluate Neuroendocrine tumors
    Bern , Switzerland
    Thu 29
    Research Summary Presentations
    In vivo models of different subtypes of paragangliomas (PPGL)
    Thu 29
    Research Summary Presentations
    Identification of Metastatic Factors by Somatic Gene Transfer in Mouse Model
    New York, USA
    17:30 - 17:40 
    Closing remarks from Founding Group Chair
    Kate Lines (Oxford, UK)
    19:00 - 23:59 
    Conference Dinner

    09:15 - 09:50 
    Refreshments and Networking
    09:50 - 10:00 
    Welcome from Founding Group Chair
    Kate Lines (Oxford, UK)
    10:00 - 10:30 
    Establishing neuroendocrine neoplasia cell lines - strategies and pitfalls
    Speaker: Joerg Schrader (Husum, Germany)
    10:30 - 12:30 
    Interactive Workshop
    Participative session where all delegates can discuss challenges and opportunities in the field, share experiences, and work towards the development of new NET models.
    Chairs: Lead by; Kate Lines (Oxford, UK), Po Hien Ear (Iowa, USA) & Ilaria Marinoni (Bern, Switzerland)
    12:30 - 13:30 
    Lunch and Networking
    13:30 - 15:00 
    Interactive Workshop continued
    Participative session where all delegates can discuss challenges and opportunities in the field, share experiences, and work towards the development of new NET models.
    Chairs: Lead by; Kate Lines (Oxford, UK), Po Hien Ear (Iowa, USA) & Ilaria Marinoni (Bern, Switzerland)
    15:00 - 15:15 
    Thank you and close from Founding Group Chair
    Kate Lines (Oxford, UK)
Amit Tirosh
Thu 29
Research Summary Presentations
VHL-deficient cell line
Anna Battistella
Milan, Italy
Thu 29
Research Summary Presentations
Development of new 3D in vitro models of Pancreatic Neuroendocrine Tumors (PanNET)
Milan, Italy
Floryne Buishand
London, United Kingdom
Thu 29
Research Summary Presentations
Canine insulinoma: a model for human malignant insulinoma
London, United Kingdom
Suganthi Chittaranjan
Vancouver, Canada
Thu 29
Research Summary Presentations
Pancreatic neuroendocrine neoplasms: exploring subgroup-defining biomarkers and therapeutic vulnerabilities in PNEN models
Vancouver, Canada
Yi-Chieh Nancy Du
New York, USA
Thu 29
Research Summary Presentations
Identification of Metastatic Factors by Somatic Gene Transfer in Mouse Model
New York, USA
Ines Marques
Bern , Switzerland
Thu 29
Research Summary Presentations
Zebrafish patient derived xenografts as a tool for precision medicine: establishment of an in-vivo pipeline to evaluate Neuroendocrine tumors
Bern , Switzerland
Natalia Pellegata
Thu 29
Research Summary Presentations
In vivo models of different subtypes of paragangliomas (PPGL)
Samira Sadowski
Bethesda, USA
Thu 29
Research Summary Presentations
Therapeutic Screening in Patient Derived Organoids for Gastroenteropancreatic Neuroendocrine tumors
Bethesda, USA
Thu 29
Research Summary Presentations
VHL-deficient cell line
Thu 29
Research Summary Presentations
Canine insulinoma: a model for human malignant insulinoma
London, United Kingdom
Thu 29
Research Summary Presentations
Pancreatic neuroendocrine neoplasms: exploring subgroup-defining biomarkers and therapeutic vulnerabilities in PNEN models
Vancouver, Canada
Thu 29
Research Summary Presentations
Development of new 3D in vitro models of Pancreatic Neuroendocrine Tumors (PanNET)
Milan, Italy
Thu 29
Research Summary Presentations
Therapeutic Screening in Patient Derived Organoids for Gastroenteropancreatic Neuroendocrine tumors
Bethesda, USA
Thu 29
Research Summary Presentations
Zebrafish patient derived xenografts as a tool for precision medicine: establishment of an in-vivo pipeline to evaluate Neuroendocrine tumors
Bern , Switzerland
Thu 29
Research Summary Presentations
In vivo models of different subtypes of paragangliomas (PPGL)
Thu 29
Research Summary Presentations
Identification of Metastatic Factors by Somatic Gene Transfer in Mouse Model
New York, USA
Fri 01 10:30
Interactive Workshop
Participative session where all delegates can discuss challenges and opportunities in the field, share experiences, and work towards the development of new NET models.
Chairs: Lead by; Kate Lines (Oxford, UK), Po Hien Ear (Iowa, USA) & Ilaria Marinoni (Bern, Switzerland)
Fri 01 13:30
Interactive Workshop continued
Participative session where all delegates can discuss challenges and opportunities in the field, share experiences, and work towards the development of new NET models.
Chairs: Lead by; Kate Lines (Oxford, UK), Po Hien Ear (Iowa, USA) & Ilaria Marinoni (Bern, Switzerland)
Thu 29 13:20
Welcome from Founding Group Chair
Kate Lines (Oxford, UK)
Thu 29 13:30
NET Research Overview
Speaker: Raj Thakker (Oxford, UK)
Thu 29 17:30
Closing remarks from Founding Group Chair
Kate Lines (Oxford, UK)
Fri 01 09:50
Welcome from Founding Group Chair
Kate Lines (Oxford, UK)
Fri 01 10:00
Establishing neuroendocrine neoplasia cell lines - strategies and pitfalls
Speaker: Joerg Schrader (Husum, Germany)
Fri 01 15:00
Thank you and close from Founding Group Chair
Kate Lines (Oxford, UK)
Thu 29 12:00
Registration and Lunch
Thu 29 19:00
Conference Dinner
Fri 01 09:15
Refreshments and Networking
Fri 01 12:30
Lunch and Networking

0 result(s) found.